Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
| ▸ | CRHBP | P24387 | 1/20 | 0.30 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17341414 | 0.95 | ALOX5 (0.34) | ALOX5KDM4EATML3MBTL1 | |
| SCHEMBL12088627 | 0.93 | ALOX5 (0.32) | ALOX5KDM4EATML3MBTL1 | |
| SCHEMBL12088468 | 0.93 | KDM4E (0.31) | ALOX5KDM4EATML3MBTL1 | |
| SCHEMBL14756619 | 0.92 | ALOX5 (0.34) | ALOX5KDM4EATML3MBTL1TSPO | |
| SCHEMBL17953820 | 0.90 | ATM (0.38) | ALOX5KDM4EATML3MBTL1TSPO | |
| SCHEMBL17953831 | 0.90 | ATM (0.38) | ALOX5KDM4EATML3MBTL1TSPO | |
| SCHEMBL17341329 | 0.90 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL17341228 | 0.90 | L3MBTL1 (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL17953765 | 0.90 | ATM (0.42) | ALOX5KDM4EATML3MBTL1TSPO | |
| SCHEMBL17953856 | 0.90 | ALOX5 (0.36) | ALOX5KDM4EATML3MBTL1GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10622569-B2 | Compound, organic electroluminescent element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-14 | — | — | US | disclosed |
| US-20160218299-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-28 | — | — | US | disclosed |
| US-20160218299-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160218299-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | EFNA1, L1CAM, LEF1 | ALOX5 1556/4885KDM4E 2030/4885ATM 3520/4885 |
| US-10622569-B2 | Compound, organic electroluminescent element, and electronic device | EFNA1, L1CAM, LEF1 | ALOX5 1556/4885KDM4E 2030/4885ATM 3520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.